These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 18259609)

  • 1. Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice.
    Liu C; Lou Y; Lizée G; Qin H; Liu S; Rabinovich B; Kim GJ; Wang YH; Ye Y; Sikora AG; Overwijk WW; Liu YJ; Wang G; Hwu P
    J Clin Invest; 2008 Mar; 118(3):1165-75. PubMed ID: 18259609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune adjuvant efficacy of CpG oligonucleotide in cancer treatment is founded specifically upon TLR9 function in plasmacytoid dendritic cells.
    Nierkens S; den Brok MH; Garcia Z; Togher S; Wagenaars J; Wassink M; Boon L; Ruers TJ; Figdor CG; Schoenberger SP; Adema GJ; Janssen EM
    Cancer Res; 2011 Oct; 71(20):6428-37. PubMed ID: 21788345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cetuximab-activated natural killer and dendritic cells collaborate to trigger tumor antigen-specific T-cell immunity in head and neck cancer patients.
    Srivastava RM; Lee SC; Andrade Filho PA; Lord CA; Jie HB; Davidson HC; López-Albaitero A; Gibson SP; Gooding WE; Ferrone S; Ferris RL
    Clin Cancer Res; 2013 Apr; 19(7):1858-72. PubMed ID: 23444227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated natural killer cell-mediated immunity is required for the inhibition of tumor metastasis by dendritic cell vaccination.
    Kim A; Noh YW; Kim KD; Jang YS; Choe YK; Lim JS
    Exp Mol Med; 2004 Oct; 36(5):428-43. PubMed ID: 15557815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered functions of plasmacytoid dendritic cells and reduced cytolytic activity of natural killer cells in patients with chronic HBV infection.
    Martinet J; Dufeu-Duchesne T; Bruder Costa J; Larrat S; Marlu A; Leroy V; Plumas J; Aspord C
    Gastroenterology; 2012 Dec; 143(6):1586-1596.e8. PubMed ID: 22960656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRAIL-mediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cell-activated natural killer cells.
    Lelaidier M; Dìaz-Rodriguez Y; Cordeau M; Cordeiro P; Haddad E; Herblot S; Duval M
    Oncotarget; 2015 Oct; 6(30):29440-55. PubMed ID: 26320191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMGB1 Is Involved in IFN-α Production and TRAIL Expression by HIV-1-Exposed Plasmacytoid Dendritic Cells: Impact of the Crosstalk with NK Cells.
    Saïdi H; Bras M; Formaglio P; Melki MT; Charbit B; Herbeuval JP; Gougeon ML
    PLoS Pathog; 2016 Feb; 12(2):e1005407. PubMed ID: 26871575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OX40 ligand expressed by DCs costimulates NKT and CD4+ Th cell antitumor immunity in mice.
    Zaini J; Andarini S; Tahara M; Saijo Y; Ishii N; Kawakami K; Taniguchi M; Sugamura K; Nukiwa T; Kikuchi T
    J Clin Invest; 2007 Nov; 117(11):3330-8. PubMed ID: 17975668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD40-independent natural killer-cell help promotes dendritic cell vaccine-induced T-cell immunity against endogenous B-cell lymphoma.
    Hömberg N; Adam C; Riedel T; Brenner C; Flatley A; Röcken M; Mocikat R
    Int J Cancer; 2014 Dec; 135(12):2825-33. PubMed ID: 24771135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmacytoid dendritic cells cross-prime naive CD8 T cells by transferring antigen to conventional dendritic cells through exosomes.
    Fu C; Peng P; Loschko J; Feng L; Pham P; Cui W; Lee KP; Krug AB; Jiang A
    Proc Natl Acad Sci U S A; 2020 Sep; 117(38):23730-23741. PubMed ID: 32879009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells and NK cells stimulate bystander T cell activation in response to TLR agonists through secretion of IFN-alpha beta and IFN-gamma.
    Kamath AT; Sheasby CE; Tough DF
    J Immunol; 2005 Jan; 174(2):767-76. PubMed ID: 15634897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation.
    Xu D; Gu P; Pan PY; Li Q; Sato AI; Chen SH
    Int J Cancer; 2004 Apr; 109(4):499-506. PubMed ID: 14991570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human plasmacytoid predendritic cells activate NK cells through glucocorticoid-induced tumor necrosis factor receptor-ligand (GITRL).
    Hanabuchi S; Watanabe N; Wang YH; Wang YH; Ito T; Shaw J; Cao W; Qin FX; Liu YJ
    Blood; 2006 May; 107(9):3617-23. PubMed ID: 16397134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective induction of therapeutic antitumor immunity by dendritic cells coexpressing interleukin-18 and tumor antigen.
    Xia D; Zheng S; Zhang W; He L; Wang Q; Pan J; Zhang L; Wang J; Cao X
    J Mol Med (Berl); 2003 Sep; 81(9):585-96. PubMed ID: 12937899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
    Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
    J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of immune factors regulating antitumor immunity using polymeric vaccines with multiple adjuvants.
    Ali OA; Verbeke C; Johnson C; Sands RW; Lewin SA; White D; Doherty E; Dranoff G; Mooney DJ
    Cancer Res; 2014 Mar; 74(6):1670-81. PubMed ID: 24480625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-15 and type I interferon are required for activation of tumoricidal NK cells by virus-infected dendritic cells.
    Boudreau JE; Stephenson KB; Wang F; Ashkar AA; Mossman KL; Lenz LL; Rosenthal KL; Bramson JL; Lichty BD; Wan Y
    Cancer Res; 2011 Apr; 71(7):2497-506. PubMed ID: 21307131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Plasmacytoid and Monocyte-Derived Dendritic Cells Display Distinct Metabolic Profile Upon RIG-I Activation.
    Fekete T; Sütö MI; Bencze D; Mázló A; Szabo A; Biro T; Bacsi A; Pazmandi K
    Front Immunol; 2018; 9():3070. PubMed ID: 30622542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG-Oligodeoxynucleotides activate tyrosinase-related protein 2-specific T lymphocytes but do not lead to a protective tumor-specific memory response.
    Sfondrini L; Besusso D; Bronte V; Macino B; Rossini A; Colombo MP; Ménard S; Balsari A
    Cancer Immunol Immunother; 2004 Aug; 53(8):697-704. PubMed ID: 15034674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG-A stimulates Hsp72 secretion from plasmacytoid dendritic cells, facilitating cross-presentation.
    Tanaka T; Kajiwara T; Kutomi G; Kurotaki T; Saito K; Kanaseki T; Tsukahara T; Hirohashi Y; Torigoe T; Hirata K; Okamoto Y; Sato N; Tamura Y
    Immunol Lett; 2015 Sep; 167(1):34-40. PubMed ID: 26141624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.